Selective δ opioid receptor agonists for inflammatory and neuropathic pain
- 1 March 2001
- journal article
- Published by Elsevier in Il Farmaco
- Vol. 56 (1-2) , 117-119
- https://doi.org/10.1016/s0014-827x(01)01020-5
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization studyNeuroscience, 1999
- Discovery of a Novel Class of Substituted Pyrrolooctahydroisoquinolines as Potent and Selective δ Opioid Agonists, Based on an Extension of the Message−Address ConceptJournal of Medicinal Chemistry, 1997
- Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implicationsTrends in Neurosciences, 1995
- THE ROLE OF THE “SPACER" IN THE OCTAHYDROISOQUINOLINE SERIES: DISCOVERY OF SB 213698, A NON-PEPTIDIC, POTENT AND SELECTIVE DELTA OPIOID AGONISTAnalgesia, 1995
- Opiophobia and cancer pain in EuropeThe Lancet, 1993
- Development of Delta Opioid Peptides as Nonaddicting AnalgesicsPharmaceutical Research, 1991
- Application of the message-address concept in the design of highly potent and selective non-peptide .delta. opioid receptor antagonistsJournal of Medicinal Chemistry, 1988
- A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesiaPAIN®, 1988